Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.

Structural studies on a hereditary abnormal prothrombin, prothrombin Salakta, have been performed to identify the difference responsible for its reduced fibrinogen clotting activity and its reduced esterase activity. Amino acid composition and sequence analyses of a peptide isolated from a lysylendopeptidase digest of the abnormal thrombin indicated that Glu-466 had been replaced by Ala. This amino acid substitution can result from a single nucleotide change in the codon for Glu-466 (GAG----GCG). The model building and the molecular dynamics simulation of thrombin Salakta suggest that the Glu-466----Ala substitution would change the proper conformation around the substrate binding site containing Trp-468, which is a unique surface loop on the thrombin molecule. This is the experimental and theoretical evidence supporting the role of the surface loop containing Trp-468 for the proper conformation of the substrate binding site.

[1]  A. Yoshioka,et al.  Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities. , 1991, Biochemistry.

[2]  J. Nishioka,et al.  Localization of thrombomodulin-binding site within human thrombin. , 1990, The Journal of biological chemistry.

[3]  R. Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.

[4]  B. Furie,et al.  Molecular defects of factor IX Chicago-2 (Arg 145----His) and prothrombin Madrid (Arg 271----cys): arginine mutations that preclude zymogen activation. , 1989, Blood.

[5]  K. Mann,et al.  Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity. , 1989, Biochemistry.

[6]  K. Mann,et al.  Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382. , 1988, Biochemistry.

[7]  J. Elion,et al.  Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant. , 1988, Blood.

[8]  S. Iwanaga,et al.  PROTHROMBIN TOKUSHIMA: A REPLACEMENT OF ARGININE-418 BY TRYPTOPHAN THAT IMPAIRS THE FIBRINOGEN CLOTTING ACTIVITY OF DERIVED THROMBIN TOKUSHIMA , 1987, Thrombosis and Haemostasis.

[9]  B. Furie,et al.  Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273. , 1986, The Journal of biological chemistry.

[10]  C. Soria,et al.  Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin. , 1984, Thrombosis research.

[11]  R. MacGillivray,et al.  Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. , 1983, Biochemistry.

[12]  Y. Sakata,et al.  Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Andrew Dearing,et al.  Studies of nucleotide conformations and interactions. The relative stabilities of double‐helical B‐DNA sequence isomers , 1981, Biopolymers.

[14]  L. Hood,et al.  A gas-liquid solid phase peptide and protein sequenator. , 1981, The Journal of biological chemistry.

[15]  K. Nakamura,et al.  Studies on a new proteolytic enzyme from Achromobacter lyticus M497-1. II. specificity and inhibition studies of Achromobacter protease I. , 1981, Biochimica et biophysica acta.

[16]  M. Hermodson,et al.  Separation of large denatured peptides by reverse phase high performance liquid chromatography. Trifluoroacetic acid as a peptide solvent. , 1980, The Journal of biological chemistry.

[17]  K. Mann,et al.  Primary structure of human prethrombin 2 and alpha-thrombin. , 1977, The Journal of biological chemistry.

[18]  D. Hewett‐Emmett,et al.  Amino acid sequence of human prothrombin fragments 1 and 2. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[20]  A. Thompson,et al.  Human thrombin: partial primary structure. , 1977, Archives of biochemistry and biophysics.

[21]  K. Mann,et al.  Human prothrombin activation. , 1975, The Journal of biological chemistry.

[22]  H. Neurath,et al.  Determination of the amino acid sequence of porcine trypsin by sequenator analysis , 1973 .